June 1, 1983

A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma

JRJoseph RubinMayo Clinic in Arizona SSScot SorensenPrairie View A&M University ASAllan J. SchuttMayo Clinic

Key Points

Key points are not available for this paper at this time.

Abstract

Rubin, Joseph M.D.; Sorensen, Scot M.D.; Schutt, Allan J. M.D.; van Hazel, Guy A. M.B.; O'Connell, Michael J. M.D.; Moertel, Charles G. M.D. Author Information

KI fragen

Bookmark

View Full Paper